Interplay between oncogene-induced DNA damage response and heterochromatin in senescence and cancer

Raffaella Di Micco, Gabriele Sulli, Miryana Dobreva, Michalis Liontos, Oronza A. Botrugno, Gaetano Gargiulo, Roberto Dal Zuffo, Valentina Matti, Giovanni D'Ario, Erica Montani, Ciro Mercurio, William C. Hahn, Vassilis Gorgoulis, Saverio Minucci, Fabrizio D'Adda Di Fagagna

Research output: Contribution to journalArticle

188 Citations (Scopus)

Abstract

Two major mechanisms have been causally implicated in the establishment of cellular senescence: the activation of the DNA damage response (DDR) pathway and the formation of senescence-associated heterochromatic foci (SAHF). Here we show that in human fibroblasts resistant to premature p16 INK4a induction, SAHF are preferentially formed following oncogene activation but are not detected during replicative cellular senescence or on exposure to a variety of senescence-inducing stimuli. Oncogene-induced SAHF formation depends on DNA replication and ATR (ataxia telangiectasia and Rad3-related). Inactivation of ATM (ataxia telangiectasia mutated) or p53 allows the proliferation of oncogene-expressing cells that retain increased heterochromatin induction. In human cancers, levels of heterochromatin markers are higher than in normal tissues, and are independent of the proliferative index or stage of the tumours. Pharmacological and genetic perturbation of heterochromatin in oncogene-expressing cells increase DDR signalling and lead to apoptosis. In vivo, a histone deacetylase inhibitor (HDACi) causes heterochromatin relaxation, increased DDR, apoptosis and tumour regression. These results indicate that heterochromatin induced by oncogenic stress restrains DDR and suggest that the use of chromatin-modifying drugs in cancer therapies may benefit from the study of chromatin and DDR status of tumours.

Original languageEnglish
Pages (from-to)292-302
Number of pages11
JournalNature Cell Biology
Volume13
Issue number3
DOIs
Publication statusPublished - Mar 2011

Fingerprint

Heterochromatin
Oncogenes
DNA Damage
Cell Aging
Ataxia Telangiectasia
Neoplasms
Chromatin
Apoptosis
Histone Deacetylase Inhibitors
DNA Replication
Fibroblasts
Pharmacology
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Cell Biology

Cite this

Di Micco, R., Sulli, G., Dobreva, M., Liontos, M., Botrugno, O. A., Gargiulo, G., ... D'Adda Di Fagagna, F. (2011). Interplay between oncogene-induced DNA damage response and heterochromatin in senescence and cancer. Nature Cell Biology, 13(3), 292-302. https://doi.org/10.1038/ncb2170

Interplay between oncogene-induced DNA damage response and heterochromatin in senescence and cancer. / Di Micco, Raffaella; Sulli, Gabriele; Dobreva, Miryana; Liontos, Michalis; Botrugno, Oronza A.; Gargiulo, Gaetano; Dal Zuffo, Roberto; Matti, Valentina; D'Ario, Giovanni; Montani, Erica; Mercurio, Ciro; Hahn, William C.; Gorgoulis, Vassilis; Minucci, Saverio; D'Adda Di Fagagna, Fabrizio.

In: Nature Cell Biology, Vol. 13, No. 3, 03.2011, p. 292-302.

Research output: Contribution to journalArticle

Di Micco, R, Sulli, G, Dobreva, M, Liontos, M, Botrugno, OA, Gargiulo, G, Dal Zuffo, R, Matti, V, D'Ario, G, Montani, E, Mercurio, C, Hahn, WC, Gorgoulis, V, Minucci, S & D'Adda Di Fagagna, F 2011, 'Interplay between oncogene-induced DNA damage response and heterochromatin in senescence and cancer', Nature Cell Biology, vol. 13, no. 3, pp. 292-302. https://doi.org/10.1038/ncb2170
Di Micco, Raffaella ; Sulli, Gabriele ; Dobreva, Miryana ; Liontos, Michalis ; Botrugno, Oronza A. ; Gargiulo, Gaetano ; Dal Zuffo, Roberto ; Matti, Valentina ; D'Ario, Giovanni ; Montani, Erica ; Mercurio, Ciro ; Hahn, William C. ; Gorgoulis, Vassilis ; Minucci, Saverio ; D'Adda Di Fagagna, Fabrizio. / Interplay between oncogene-induced DNA damage response and heterochromatin in senescence and cancer. In: Nature Cell Biology. 2011 ; Vol. 13, No. 3. pp. 292-302.
@article{12bb2308551749a7981417a97fc4e1a9,
title = "Interplay between oncogene-induced DNA damage response and heterochromatin in senescence and cancer",
abstract = "Two major mechanisms have been causally implicated in the establishment of cellular senescence: the activation of the DNA damage response (DDR) pathway and the formation of senescence-associated heterochromatic foci (SAHF). Here we show that in human fibroblasts resistant to premature p16 INK4a induction, SAHF are preferentially formed following oncogene activation but are not detected during replicative cellular senescence or on exposure to a variety of senescence-inducing stimuli. Oncogene-induced SAHF formation depends on DNA replication and ATR (ataxia telangiectasia and Rad3-related). Inactivation of ATM (ataxia telangiectasia mutated) or p53 allows the proliferation of oncogene-expressing cells that retain increased heterochromatin induction. In human cancers, levels of heterochromatin markers are higher than in normal tissues, and are independent of the proliferative index or stage of the tumours. Pharmacological and genetic perturbation of heterochromatin in oncogene-expressing cells increase DDR signalling and lead to apoptosis. In vivo, a histone deacetylase inhibitor (HDACi) causes heterochromatin relaxation, increased DDR, apoptosis and tumour regression. These results indicate that heterochromatin induced by oncogenic stress restrains DDR and suggest that the use of chromatin-modifying drugs in cancer therapies may benefit from the study of chromatin and DDR status of tumours.",
author = "{Di Micco}, Raffaella and Gabriele Sulli and Miryana Dobreva and Michalis Liontos and Botrugno, {Oronza A.} and Gaetano Gargiulo and {Dal Zuffo}, Roberto and Valentina Matti and Giovanni D'Ario and Erica Montani and Ciro Mercurio and Hahn, {William C.} and Vassilis Gorgoulis and Saverio Minucci and {D'Adda Di Fagagna}, Fabrizio",
year = "2011",
month = "3",
doi = "10.1038/ncb2170",
language = "English",
volume = "13",
pages = "292--302",
journal = "Nature Cell Biology",
issn = "1465-7392",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Interplay between oncogene-induced DNA damage response and heterochromatin in senescence and cancer

AU - Di Micco, Raffaella

AU - Sulli, Gabriele

AU - Dobreva, Miryana

AU - Liontos, Michalis

AU - Botrugno, Oronza A.

AU - Gargiulo, Gaetano

AU - Dal Zuffo, Roberto

AU - Matti, Valentina

AU - D'Ario, Giovanni

AU - Montani, Erica

AU - Mercurio, Ciro

AU - Hahn, William C.

AU - Gorgoulis, Vassilis

AU - Minucci, Saverio

AU - D'Adda Di Fagagna, Fabrizio

PY - 2011/3

Y1 - 2011/3

N2 - Two major mechanisms have been causally implicated in the establishment of cellular senescence: the activation of the DNA damage response (DDR) pathway and the formation of senescence-associated heterochromatic foci (SAHF). Here we show that in human fibroblasts resistant to premature p16 INK4a induction, SAHF are preferentially formed following oncogene activation but are not detected during replicative cellular senescence or on exposure to a variety of senescence-inducing stimuli. Oncogene-induced SAHF formation depends on DNA replication and ATR (ataxia telangiectasia and Rad3-related). Inactivation of ATM (ataxia telangiectasia mutated) or p53 allows the proliferation of oncogene-expressing cells that retain increased heterochromatin induction. In human cancers, levels of heterochromatin markers are higher than in normal tissues, and are independent of the proliferative index or stage of the tumours. Pharmacological and genetic perturbation of heterochromatin in oncogene-expressing cells increase DDR signalling and lead to apoptosis. In vivo, a histone deacetylase inhibitor (HDACi) causes heterochromatin relaxation, increased DDR, apoptosis and tumour regression. These results indicate that heterochromatin induced by oncogenic stress restrains DDR and suggest that the use of chromatin-modifying drugs in cancer therapies may benefit from the study of chromatin and DDR status of tumours.

AB - Two major mechanisms have been causally implicated in the establishment of cellular senescence: the activation of the DNA damage response (DDR) pathway and the formation of senescence-associated heterochromatic foci (SAHF). Here we show that in human fibroblasts resistant to premature p16 INK4a induction, SAHF are preferentially formed following oncogene activation but are not detected during replicative cellular senescence or on exposure to a variety of senescence-inducing stimuli. Oncogene-induced SAHF formation depends on DNA replication and ATR (ataxia telangiectasia and Rad3-related). Inactivation of ATM (ataxia telangiectasia mutated) or p53 allows the proliferation of oncogene-expressing cells that retain increased heterochromatin induction. In human cancers, levels of heterochromatin markers are higher than in normal tissues, and are independent of the proliferative index or stage of the tumours. Pharmacological and genetic perturbation of heterochromatin in oncogene-expressing cells increase DDR signalling and lead to apoptosis. In vivo, a histone deacetylase inhibitor (HDACi) causes heterochromatin relaxation, increased DDR, apoptosis and tumour regression. These results indicate that heterochromatin induced by oncogenic stress restrains DDR and suggest that the use of chromatin-modifying drugs in cancer therapies may benefit from the study of chromatin and DDR status of tumours.

UR - http://www.scopus.com/inward/record.url?scp=79952268809&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952268809&partnerID=8YFLogxK

U2 - 10.1038/ncb2170

DO - 10.1038/ncb2170

M3 - Article

C2 - 21336312

AN - SCOPUS:79952268809

VL - 13

SP - 292

EP - 302

JO - Nature Cell Biology

JF - Nature Cell Biology

SN - 1465-7392

IS - 3

ER -